Sleep Apnea and Epilepsy: Why Nighttime Breathing Matters

When someone with epilepsy feels exhausted, seizures and antiseizure medications are obvious possibilities. But disrupted nighttime breathing can also leave a person tired despite spending eight hours in bed. Obstructive sleep apnea deserves attention because it is common, diagnosable and treatable. The evidence is strongest for improving sleep and daytime symptoms; any effect on seizure control is less certain.

What sleep apnea does during the night

Obstructive sleep apnea (OSA) repeatedly narrows or closes the upper airway during sleep. Breathing interruptions, oxygen changes and brief arousals can fragment sleep even when the person does not remember waking. Loud snoring, witnessed pauses, gasping, morning headache and daytime fatigue are common clues, but symptoms vary. The National Heart, Lung, and Blood Institute explains why an apparently full night of sleep can still leave someone exhausted.

Why epilepsy and sleep apnea belong in the same conversation

Sleep disruption may contribute to seizure susceptibility, while seizures, medication effects, pain and other conditions can also interfere with sleep. A 2017 meta-analysis estimated OSA in roughly one-third of people with epilepsy across included studies, but the estimate varies by population and testing. A 2026 Epilepsia review considers OSA a potentially modifiable factor while emphasizing confounding, selection bias and limited randomized evidence. These findings justify investigating symptoms, not promising that treating apnea will eliminate seizures.

What treating sleep apnea may—and may not—change

Positive airway pressure (PAP or CPAP) helps hold the airway open. Evidence supports its use for appropriate patients with diagnosed OSA, particularly those with excessive daytime sleepiness. The American Academy of Sleep Medicine guideline summarizes these established benefits. Whether CPAP reduces seizures is less certain: observational studies report encouraging associations, but treatment adherence and patient differences can distort comparisons. A 2008 randomized pilot trial of 35 adults was too small to establish a reliable seizure benefit. CPAP is not a substitute for antiseizure treatment. Nor has treating OSA been proven to prevent SUDEP; see Reducing Your SUDEP Risk for broader seizure safety.

Warning signs that warrant a closer look

A bed partner may notice breathing pauses, gasps or loud snoring. Someone sleeping alone may instead notice unrefreshing sleep, headaches, concentration problems or daytime sleepiness. These symptoms can overlap with epilepsy and medication effects, so worsening or persistent problems deserve their own assessment. Body weight is one risk factor, but OSA occurs at many body sizes. A wearable alert or screening questionnaire does not establish a diagnosis.

How sleep apnea is evaluated

Evaluation begins with symptoms and a clinical history, followed by objective testing when indicated. Laboratory polysomnography records sleep and breathing signals. Home sleep apnea testing may be appropriate for certain uncomplicated adults with a high likelihood of moderate-to-severe OSA. The AASM diagnostic guideline cautions against diagnosing OSA from questionnaires alone and recommends laboratory testing after a negative or inconclusive home study when suspicion persists. A home apnea test is not an epilepsy video-EEG test. If unusual nighttime spells are part of the concern, neurologists and sleep specialists may need to coordinate testing.

Treatment involves more than a machine

Mask fit, pressure settings, comfort and adherence matter when PAP is prescribed. Selected patients may be candidates for oral appliances, positional therapy, weight management or other interventions based on their particular anatomy and disease severity. Treating apnea does not automatically resolve insomnia, pain-related awakenings, medication-related fatigue or other sleep disorders. Assess success through objective breathing control and everyday functioning. Tracking seizure frequency may be useful, but an apparent change alone does not prove causation.

Nocturnal seizures, medications and implanted devices

Nighttime gasping or unusual movements can have more than one explanation. A witness description can help, but diagnosis requires appropriate evaluation. Antiseizure medications may affect sleep and alertness, and changes should be made with the prescriber rather than as an experiment. Vagus nerve stimulation (VNS) can also affect breathing in some patients: a small 2022 study identified worsened sleep-disordered-breathing measures after VNS. This does not mean every VNS user has apnea, but new symptoms merit a conversation with the treating team.

Questions to bring to your appointment

Ask whether fatigue or nighttime awakenings could reflect OSA rather than only seizures or medication effects. Ask which sleep test is appropriate and whether unusual nighttime events need EEG monitoring as well. Discuss medications or implanted devices that might affect breathing. If OSA is diagnosed, agree on how treatment success will be measured, which symptoms to track, and how the neurology and sleep teams will coordinate care.

The bottom line

OSA is common enough in epilepsy care, and sufficiently treatable, that persistent symptoms deserve a direct question about it. Evidence for diagnosing and treating OSA is stronger than evidence that apnea treatment reliably reduces seizures. Keeping those conclusions separate avoids both neglect and overpromising. For broader context see Sleep and Recovery.

Sources & Further Reading

• Rehim et al., Epilepsia, 2026
• OSA in epilepsy: 2017 meta-analysis
• CPAP in epilepsy: randomized pilot trial
• AASM diagnostic guideline
• AASM PAP treatment guideline
• NHLBI sleep apnea symptoms